Theregen, Inc. is a regenerative medicine company that is developing cell-based therapies
for cardiovascular indications. Anginera™, Theregen's lead product, is an epicardial patch designed to improve cardiac function in patients.

What's new?

08/23/08
Anginera featured on ABC News
Courtesy KGO, Ch.7, San Francisco.
 
07/30/08
AHA Release: Patch May Prevent Heart Failure after Heart Attack

---